Tumor Lysis Syndrome

What is tumor lysis syndrome?

Tumor lysis syndrome (often shortened to TLS) is a serious medical emergency that can happen when a large number of cancer cells die within a short period of time. The word lysis means the breaking open of cells. When cancer cells break apart, they release their contents into the bloodstream. These contents include potassium, phosphate, and nucleic acids (the building blocks of DNA), which the body converts into uric acid. Normally the kidneys clear these substances without difficulty. In tumor lysis syndrome, they are released faster than the kidneys can remove them, and the resulting chemical imbalances can affect the heart, kidneys, muscles, and nervous system.

Tumor lysis syndrome most often occurs in the first hours to days after cancer treatment begins, especially chemotherapy. It is seen most frequently in people with fast-growing blood cancers such as acute leukemia (cancer of the white blood cells) and aggressive lymphoma (cancer of the lymph system). Less commonly, it can occur in people with solid tumors, and in rare cases it develops on its own before any treatment is given, which doctors call spontaneous tumor lysis syndrome.

Because it is closely linked to cancer care, tumor lysis syndrome is usually anticipated, prevented, and managed by oncology teams. At Acibadem, this care falls under the Medical Oncology Department, typically working alongside kidney specialists (nephrologists) and intensive care teams when needed.

Tumor lysis syndrome symptoms

Tumor lysis syndrome symptoms are caused by the chemical changes in the blood rather than by the cancer itself. In the early stages, many people have no symptoms at all, and the problem is found only through blood tests. This is one reason why doctors monitor blood work closely when treatment starts in people at risk. When symptoms do appear, they may include:

• Nausea, vomiting, or loss of appetite
• Diarrhea
• Muscle cramps, twitching, or weakness
• Tingling or numbness around the mouth, hands, or feet
• Passing much less urine than usual, or dark urine
• Fatigue or feeling generally unwell
• An irregular, fast, or slow heartbeat, or palpitations
• Confusion, restlessness, or drowsiness
• Seizures
• Swelling of the legs or fluid buildup

Doctors often describe two forms. Laboratory tumor lysis syndrome means blood tests show abnormal levels of potassium, phosphate, uric acid, or calcium, but the person may not feel unwell yet. Clinical tumor lysis syndrome means these laboratory changes have started to cause harm, such as kidney injury, heart rhythm problems, seizures, or in the most severe cases, sudden death. The goal of monitoring is to catch the laboratory stage before it progresses to the clinical stage.

Different chemical imbalances tend to produce different symptoms. High potassium (hyperkalemia) mainly affects the heart and muscles, causing weakness and dangerous heart rhythms. High phosphate (hyperphosphatemia) binds with calcium, which lowers calcium levels in the blood (hypocalcemia) and can cause cramps, tingling, and seizures. High uric acid (hyperuricemia) and calcium-phosphate crystals can clog the small filtering tubes of the kidneys, leading to reduced urine output and acute kidney injury.

Causes and risk factors

The direct cause of tumor lysis syndrome is the rapid death of many cancer cells at once. Understanding tumor lysis syndrome causes helps explain who is most at risk and why prevention is possible.

Treatment-related causes. Most cases follow the start of cancer therapy. Chemotherapy is the most common trigger, but other treatments that kill cancer cells quickly can also lead to it, including targeted therapies, immunotherapies, some steroid treatments, radiation therapy, and certain hormone treatments. In general, the more effective and rapid a treatment is against a sensitive cancer, the more cell contents are released in a short time.

Spontaneous causes. Occasionally, very fast-growing cancers outgrow their blood supply, and large numbers of cells die on their own before treatment starts. This spontaneous form is less common but can be harder to anticipate.

Risk factors that make tumor lysis syndrome more likely include:

• Fast-growing blood cancers, particularly acute leukemias and aggressive lymphomas such as Burkitt lymphoma
• A large amount of cancer in the body (often called a high tumor burden), including a very high white blood cell count or bulky tumors
• Cancers that are highly sensitive to the treatment being given
• Existing kidney problems or reduced kidney function
• Dehydration or low urine output before treatment
• Already elevated uric acid, phosphate, or potassium levels before treatment begins
• High levels of a blood marker called lactate dehydrogenase (LDH), which reflects rapid cell turnover
• Older age or other serious health conditions
• Use of certain medicines that raise potassium or uric acid, or that reduce kidney function

Before treatment, oncology teams usually assess these factors and classify a person as low, intermediate, or high risk. This risk level guides how much preventive treatment and monitoring is planned.

Diagnosis

Tumor lysis syndrome diagnosis relies mainly on blood tests rather than imaging. Because the condition can develop quickly, doctors in many cases begin testing before treatment starts and repeat tests frequently during the first days of therapy, sometimes several times a day in high-risk patients.

Key tests include:

• Serum electrolytes: blood levels of potassium, phosphate, and calcium
• Uric acid: a waste product that rises sharply as cells break down
• Kidney function tests: creatinine and blood urea nitrogen (BUN), which rise when the kidneys are struggling
• Lactate dehydrogenase (LDH): a marker of cell turnover used mainly for risk assessment
• Complete blood count: to measure white blood cell counts and overall blood health
• Electrocardiogram (ECG): a recording of the heart’s electrical activity, used to detect rhythm changes caused by high potassium or low calcium
• Urine tests and urine output measurement: to check kidney function and look for crystals

Doctors commonly use standardized criteria to confirm the diagnosis. Laboratory tumor lysis syndrome is generally defined by two or more abnormal values (potassium, phosphate, uric acid, or calcium) occurring within a set window around the start of treatment, usually from a few days before to about a week after. Clinical tumor lysis syndrome is diagnosed when these laboratory changes are accompanied by kidney injury, an abnormal heart rhythm, seizures, or sudden death that cannot be explained by another cause. Imaging such as ultrasound or CT scans is not needed to diagnose the syndrome, but it may be used to assess tumor size or to rule out other causes of kidney problems, such as a blockage.

Tumor lysis syndrome treatment

Tumor lysis syndrome treatment has two parts: prevention in people at risk, and active management once it develops. Prevention is considered the most important element because it is far easier to avoid dangerous chemical shifts than to correct them once organ damage has begun.

Prevention and monitoring. For people at intermediate or high risk, doctors often start intravenous fluids (fluids given through a vein) before treatment begins and continue them for several days. Fluids increase urine production and help the kidneys flush out potassium, phosphate, and uric acid. Frequent blood tests are scheduled so that any rise in these substances can be addressed early. In some cases, oncologists may choose to start treatment with a gentler initial dose or a preliminary phase, so that cancer cells die more gradually.

Medicines to lower uric acid. Two main types of medication are used. Allopurinol is a tablet that blocks the body from making new uric acid. It does not remove uric acid that is already present, so it is generally used for prevention in lower-risk patients. Rasburicase is an intravenous medication that breaks down existing uric acid into a form the kidneys can remove easily. It works quickly and is often used in high-risk patients or when uric acid is already elevated. Rasburicase is not suitable for everyone; for example, people with a specific inherited enzyme deficiency (G6PD deficiency) may not be able to receive it, so testing is sometimes done first.

Correcting electrolyte imbalances. High potassium is treated urgently because of its effect on the heart. Options may include medicines that shift potassium into cells temporarily, medicines that bind potassium in the gut, and treatments that protect the heart while levels are brought down. High phosphate may be managed with medicines called phosphate binders taken with food, and by limiting phosphate in the diet during the critical period. Low calcium is usually treated only if it is causing symptoms, because giving calcium when phosphate is very high can encourage harmful crystal formation.

Dialysis and kidney support. If the kidneys cannot keep up, or if potassium or phosphate levels become dangerously high despite medication, doctors may recommend dialysis, a procedure in which a machine filters waste products and excess electrolytes from the blood. In many cases dialysis is needed only temporarily, until the tumor lysis phase passes and kidney function recovers. Some people are moved to an intensive care unit for close monitoring during this period.

Surgery and rehabilitation. Surgery is not a treatment for tumor lysis syndrome itself. Rehabilitation is rarely needed unless a complication, such as a prolonged critical illness, has caused weakness or reduced mobility, in which case physical therapy may be part of recovery.

It is important to understand that the cancer treatment causing tumor lysis is usually still the right treatment. Oncology teams aim to manage the syndrome so that effective therapy can continue safely, rather than stopping treatment altogether.

Living with tumor lysis syndrome and outlook

Unlike many conditions on this site, tumor lysis syndrome is not a long-term illness that people live with for years. It is a short-term emergency that typically occurs around the start of cancer treatment. When it is anticipated and managed early, the outlook is often good, and many people recover fully without lasting kidney damage. When it is recognized late or is very severe, it can cause permanent kidney injury or be life-threatening, which is why prevention and monitoring receive so much attention.

The overall outlook depends on several factors: how quickly the imbalances were detected, how well the kidneys were working beforehand, whether dialysis was needed, and how the underlying cancer responds to treatment. Some people need a period of kidney follow-up after recovery. Your care team can explain what your own test results mean and whether any ongoing checks are advised.

Practical steps that may help during the at-risk period include drinking fluids as directed unless you have been told to limit them, taking preventive medicines exactly as prescribed, reporting any new symptoms promptly, and telling your team about all other medicines and supplements you take, since some can raise potassium or uric acid or affect the kidneys. Your doctor may also ask you to avoid certain foods high in potassium or phosphate for a short time.

Frequently asked questions

What are the first signs of tumor lysis syndrome?

In many cases the first signs are abnormal blood test results rather than physical symptoms, which is why regular monitoring is arranged for people at risk. When symptoms occur, early ones often include nausea, vomiting, muscle cramps, weakness, tingling, and reduced urine output. Because these can also be side effects of cancer treatment, any new or worsening symptom during the first days of therapy should be reported to your care team so it can be checked.

How soon after chemotherapy does tumor lysis syndrome happen?

Tumor lysis syndrome usually develops within the first few days after cancer treatment starts, and often within the first 24 to 72 hours. It can occasionally begin shortly before treatment in the spontaneous form, or a little later depending on the type of therapy. Monitoring is typically most intense during this early window and is reduced once blood values remain stable.

Can tumor lysis syndrome be prevented?

In many cases, yes. Prevention is the main focus of tumor lysis syndrome treatment. Doctors assess risk before therapy and may use intravenous fluids, uric acid-lowering medicines such as allopurinol or rasburicase, and frequent blood tests to catch problems early. Prevention greatly reduces the risk, but it cannot remove it entirely, especially in people with very fast-growing cancers or existing kidney problems.

Is tumor lysis syndrome life-threatening?

It can be. Severe cases may cause dangerous heart rhythms, seizures, or acute kidney failure. However, when it is anticipated, detected early, and treated promptly, many people recover completely. The seriousness of any individual case depends on how high the electrolyte levels become and how quickly they are corrected.

How is tumor lysis syndrome diagnosed?

Tumor lysis syndrome diagnosis is based on blood tests that measure potassium, phosphate, uric acid, calcium, and kidney function, usually repeated frequently around the start of treatment. Doctors apply standard criteria that look for two or more abnormal values within a defined time frame. An electrocardiogram may be used to check the heart, and urine output is measured. Imaging is not required to make the diagnosis.

Which cancers are most likely to cause tumor lysis syndrome?

It is most common in fast-growing blood cancers, including acute lymphoblastic leukemia, acute myeloid leukemia with very high white cell counts, and aggressive lymphomas such as Burkitt lymphoma. It is less common in solid tumors, though it can occur, particularly when the tumor is large and responds very quickly to treatment.

Does tumor lysis syndrome cause permanent kidney damage?

Not always. In many cases kidney function recovers once the electrolyte imbalances are corrected and the period of rapid cell breakdown has passed, even if temporary dialysis was needed. In more severe or delayed cases, some degree of lasting kidney damage is possible. Your doctors may arrange follow-up kidney function tests to check recovery.

When to see a doctor

If you are receiving treatment for cancer, particularly a blood cancer, and you have been told you are at risk of tumor lysis syndrome, your care team will already be monitoring you. Even so, it is important to report symptoms as soon as they appear, because early treatment can prevent serious complications. Seek urgent medical attention, or use the emergency number in your country, if you experience any of the following during or shortly after starting cancer treatment:

• Passing very little or no urine for several hours
• A racing, pounding, irregular, or very slow heartbeat, or fainting
• Chest pain or severe shortness of breath
• Severe muscle weakness, cramps, or spasms
• Tingling or numbness around the mouth, fingers, or toes that is new or worsening
• Confusion, unusual drowsiness, or difficulty staying awake
• A seizure
• Persistent vomiting that prevents you from keeping fluids down

These signs can indicate dangerous changes in potassium, calcium, or kidney function and need immediate assessment with blood tests and heart monitoring. Do not wait for a scheduled appointment if these symptoms develop.